Gowardhan Ayur Farma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -99.55%
- Profit Growth -3472.31%
- Ebitda -366.85%
- Net Worth -164.16%
- Total Assets -31.38%
About Gowardhan Ayur Farma
Gowardhan Ayur Farma Private Limited (GAFPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2011 and has a history of 14 years and one month. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajashree Chounde and Bhagyashree Chounde serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900PN2011PTC138328
- Company No.
138328
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jan 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Gowardhan Ayur Farma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajashree Chounde  | Director | 20-Jan-2011 | Current |
| Bhagyashree Chounde | Director | 20-Jan-2011 | Current |
Financial Performance of Gowardhan Ayur Farma.
Gowardhan Ayur Farma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 99.55% decrease. The company also saw a substantial fall in profitability, with a 3472.31% decrease in profit. The company's net worth observed a substantial decline by a decrease of 164.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gowardhan Ayur Farma?
In 2019, Gowardhan Ayur Farma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shreegowardhan Nutrayur Private LimitedRajashree Chounde and Bhagyashree Chounde are mutual person
- Shree Gowardhan Mahila & Balvikas Foundation
Rajashree Chounde and Bhagyashree Chounde are mutual person
- Shreegowardhan Entertainment Llp
Bhagyashree Chounde is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gowardhan Ayur Farma?
Unlock and access historical data on people associated with Gowardhan Ayur Farma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gowardhan Ayur Farma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gowardhan Ayur Farma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
